Korea’s digital healthcare start-up Yellosis, Inc. will hold a total of 4 days from January 5th (Thursday) to 8th (Sunday, local time), 2023 in Las Vegas, USA at the Eureka Park K-STARTUP Integrated Pavilion of ‘CES 2023’. At Yellosis exhibition booth [No.#62052-23], a smart urine test kit (Cym702 Boat), an application (Cym702 App), and an ‘AI health management solution’ based on measured results will be displayed.
As the demand for self-care kits that can manage and prevent their own health at home has increased worldwide during the pandemic caused by Covid-19, Yellosis has developed a simple, smart urine test kit Cym702 Boat that makes it easy for anyone to manage their health in everyday life.
Existing urine tests have various problems that reduce the accessibility of the test, such as going to the hospital or using a diagnostic device. However, with the Cym702 Boat test kit and application developed by Yellosis, it is possible to perform a urine test and personalizes health care at home.
If you urinate into the personal urine test kit Cym702 Boat and take a picture with the app, you can immediately check the result. Quick result confirmation and self-developed color correction algorithm minimize the influence of the surrounding environment, resulting in more than 98% accurate results.
Yu Kyung Tak, Ph.D. in Pharmacy and CEO of Yellosis, a former Samsung Electronics medical device division, said, “Currently, glucose, protein, pH, occult blood, and ketones can be monitored, and disease prevention and management for more diverse targets by expanding the target and category of use. To prepare the system, we are planning and conducting development clinical trials at hospitals, health checkup centers, and pharmacies.”
CEO Tak said, “There are 1 billion people with kidney/diabetes disease worldwide, and one person dies every 6 seconds. However, 50% of patients have a problem because they cannot diagnose their
disease in advance, so early diagnosis and prevention are very important for the public. In addition, in the case of patients with diseases, periodic urine tests and personalized health management are very important to reduce the progress of the disease and the patient’s anxiety.” She emphasized the need for periodic urine tests and personalized solutions.
Introduction of Yellosis Inc.
Yellosis, which was spun off from Samsung Electronics’ C-Lab in 2020, is composed of key personnel from Samsung Electronics’ medical device division. After developing a smart urine test kit and mobile phone application for the past two years, the company plans to showcase and introduce the product to the world through CES2023. Starting with its first product, Cym702 Boat, it is also developing a smart toilet that extends the system for checking and managing personal health to the bathroom space. Currently, it is materialized to the prototype stage and is scheduled to be introduced within 2023.
